Sign inJoin waitlistJoin the waitlist

Kathryn Laurie

Physician · Atlantic Health System

Credentials: · · ·

History

Atlantic Health System
2021–Present

Ann & Robert H Lurie Children's Hospital of Chicago
2016–2017
Weill Cornell Medical Center
2013–2016
Loyola University Chicago Stritch School of Medicine
2009–2013

Research

Radiosensitization by Histone H3 Demethylase Inhibition in Diffuse Intrinsic Pontine Glioma
Clinical Cancer Research · 2019 · 66 citations
Association between end-induction response according to the revised International Neuroblastoma Response Criteria (INRC) and outcome in high-risk neuroblastoma patients
Pediatric Blood & Cancer · 2020 · 12 citations
Obesity in children with acute promyelocytic leukemia: What is its prevalence and prognostic significance?
Pediatric Blood & Cancer · 2022 · First of 12 authors · 6 citations

AO
Andrea Orsey
1 paper
Bayard Powell
1 paper
Diana Wu
1 paper
DB
Dominick Bosse
1 paper
EB
Erin Barr
1 paper
Hana Hakim
1 paper
JF
James Feusner
1 paper
Jean Levy
1 paper
Jeffery Auletta
1 paper
Jennifer Wilkes
1 paper
Jennifer Workman
1 paper
JH
Jonathan Hron
1 paper

Clinical trials

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2028
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2030
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Site PI · Recruiting · Phase 3
Children's Oncology Group
2025–2031
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2024–2029